Berkshire Bank Eli Lilly & CO Transaction History

Berkshire Bank

$398 Million
Q2 2024

A detailed history of Berkshire Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Berkshire Bank holds 3,394 shares of LLY stock, worth $2.98 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

3,394

Previous 3,475 2.33%

Holding current value

$2.98 Million

Previous $2.7 Million 13.65%

% of portfolio

0.77%

Previous 0.67%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $58,714 - $73,632	-81 Reduced 2.33%	3,394 $3.07 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $2,368 - $3,169	-4 Reduced 0.11%	3,475 $2.7 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $15,755 - $18,573	30 Added 0.87%	3,479 $2.03 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $78,246 - $107,873	-180 Reduced 4.96%	3,449 $1.85 Million
Q2 2023 Jul 12, 2023	SELL	$350.74 - $468.98 $35,074 - $46,898	-100 Reduced 2.68%	3,629 $1.7 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $7,765 - $9,120	-25 Reduced 0.67%	3,729 $1.28 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $2,964 - $3,378	-10 Reduced 0.27%	3,754 $1.21 Million
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $68,288 - $80,181	-245 Reduced 6.11%	3,764 $1.22 Million
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $77,447 - $96,247	-330 Reduced 7.61%	4,009 $1.15 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $18,055 - $23,354	-100 Reduced 2.25%	4,339 $996,000
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $164,155 - $212,507	-999 Reduced 18.37%	4,439 $829,000
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $317,670 - $420,354	-2,435 Reduced 30.93%	5,438 $918,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $1.15 Million - $1.33 Million	7,873 New	7,873 $1.17 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Bank, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Bank with notifications on news.

Account